The abstract is read at the publisher; the summary is JClub's.
In 712 CTEPH patients, prior VTE history (n=576, 80.9%) defines a distinct thrombotic phenotype with more proximal disease (92.5% vs 66.2%) and higher endarterectomy use (22.6% vs 3.7%).
- Why it matters: Prior VTE–negative CTEPH suggests biological heterogeneity, but the genetic and molecular differences between these subgroups have been unclear.
- What they did: The study used whole-genome sequencing in 712 patients plus 2952 controls, integrated with bulk RNA sequencing of pulmonary endarterectomy tissue and plasma protein quantification, and validated in tissue and primary endothelial cells.
- The result: In CTEPH-VTE(+) patients, GWAS highlighted ABO (rs676996, P =1.1×10 -9 ) and FGG (rs7681423, P =2.5×10 -8 ), and multiomics converged on CTSS, which was elevated and promoted endothelial proliferation via ERK signaling attenuated by LY3000328.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.